ReviewClinical Medicine Insights. Oncology2026

Osimertinib for Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Current Evidence.

Xiumei Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.